Detail (Experimental CeRNA)

Home Detail(Experimental CeRNA)

Basic Information

Regular Relationship :


Phenotype/DiseaseSpecie

Sepsis-Induced Acute Kidney Injury

CeRNA1

PVT1[LncRNA]

miRNA

miR-20a-5p[miRNA]

CeRNA2

NLRP3[mRNA]


Tissue/Cell line

HK-2 cells

Specie

Homo sapiens (human)

Citation

Mol Med Rep. 2021 Apr;23(4):271. doi: 10.3892/mmr.2021.11910. Epub 2021 Feb 12.


Reference title
lncRNA PVT1 modulates NLRP3-mediated pyroptosis in septic acute kidney injury by targeting miR-20a-5p.
Experimental verification
ELISA;Western blot;Flow Cytometry assay;Luciferase reporter assay;

Functional description
Acute kidney injury (AKI) is the most common complication of sepsis. The current incidence of sepsis is high (0.3% of total population) worldwide, and septic AKI may cause death in patients. Long non-coding (lnc)RNAs serve important roles in the pathogenesis of AKI. Therefore, the present study investigated the mechanism underlying lncRNA plasmacytoma variant translocation 1 (PVT1)-mediated regulation of pyroptosis in septic AKI. Septic kidney injury was induced in mice using the caecal ligation and puncture method, and lipopolysaccharide (LPS)-induced HK-2 cell models were also established. Haematoxylin-eosin staining was performed to assess pathological alterations of kidney tissues in the mice. The levels of IL-1β, IL-18 and lactate dehydrogenase were determined by conducting ELISAs. Reverse transcription-quantitative PCR was used to detect the expression levels of PVT1 and microRNA (miR)-20a-5p. To assess pyroptosis, the protein expression levels of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3), IL-1β, IL-18, apoptosis-associated speck-like protein containing a CARD and cleaved caspase-1 were measured via western blotting. Flow cytometry was performed to assess the rate of cell pyroptosis. Dual luciferase reporter assays were used to assess the binding relationships of PVT1/miR-20a-5p and miR-20a-5p/NLRP3. PVT1 expression was significantly increased, whereas miR-20a-5p expression was significantly decreased in sepsis model mice and LPS-induced HK-2 cells compared with sham mice and control HK-2 cells, respectively. PVT1 knockdown significantly suppressed cell pyroptosis and downregulated the expression of inflammatory factors in LPS-induced HK-2 cells. The results also indicated that PVT1 served as a sponge of miR-20a-5p, and miR-20a-5p directly targeted NLRP3. miR-20a-5p knockdown significantly promoted LPS-induced cell pyroptosis. Moreover, PVT1 knockdown inhibited LPS-induced cell pyroptosis by targeting the miR-20a-5p/NLRP3 signalling pathway. The results of the present study suggested that PVT1 modulated NLRP3-mediated pyroptosis in septic AKI by targeting miR-20a-5p, which might suggest significant potential therapeutic targets for septic AKI.

Annotations

External Annotation for PVT1
LncRNA-associated competing triplets and functions.
Comprehensive experimentally supported associations between lncRNA and human cancer.
Infer genomic variations that disturb lncRNA-associated ceRNA regulation..
Provide and annotate disease or phenotype-associated variants in human long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) or their regulatory elements.
Providing cellular-specific lncRNA-associated ceRNA networks predicted via high-throughput analysis of single-cell genomic data.
Information on all annotated and predicted human genes.
Gene nomenclature, gene families and associated resources (genomic, proteomic, phenotypic information).
Genome browser for vertebrate genomes.
An annotated collection of all publicly available DNA sequences.
A wiki-based platform for community curation of human long non-coding RNAs.
An integrated knowledge database dedicated to non-coding RNAs.
An integrated database of human annotated lncRNA transcripts.
Comprehensive annotations of eukaryotic long non-coding RNAs.
Comprehensive experimentally supported associations between lncRNA and human cancer.
A comprehensive, authoritative compendium of human genes and genetic phenotypes.
The catalogue of somatic mutations in cancer.

Starting a new search ...